Presidio Property Trust, Inc. (SQFT) · Nov 20, 2026 · Delisting
Nasdaq deficiency notice — $1.00 bid-price rule; compliance deadline May 17, 2027
Presidio Property Trust’s Nasdaq warning confirms a sub-$1 bid-price deficiency, giving the REIT until May 17, 2027 to regain compliance.
Presidio is a small, diversified REIT built around office, industrial, retail, and model-home properties, while managing a shrinking and financially constrained public-company platform. The filing turns a warning into a formal listing deficiency. Nasdaq says Presidio’s common stock stayed below the required $1.00 closing bid price for 30 consecutive business days, and the company has until May 17, 2027 to cure it. 〔0〕
The immediate operating impact is limited, but the capital-markets risk is real. The shares remain listed for now, and compliance requires a $1.00 closing bid for at least 10 consecutive business days. Presidio could use a reverse split if needed, while a sustained bid price of $0.10 or less for 10 trading days would trigger a much more serious delisting process. 〔1〕
This is mostly confirmation, not a fresh surprise. Presidio’s November 13, 2026 quarterly filing had already said the stock had been below $1.00 for 27 consecutive business days and that a deficiency notice was expected around November 17. The new information is the formal deadline and the exact cure framework, not a change in the underlying problem.
Bottom line: Presidio avoids an immediate delisting and has a six-month cure window, but the filing confirms a visible weakness in its public-market footing. It matters mainly as a constraint and potential reverse-split decision, not as a change to the underlying property portfolio.
Regain $1 bid price by May 17, 2027
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!